Redx Pharma

Redx Pharma company information, Employees & Contact Information

Explore related pages

Related company profiles:

Redx Pharma is a clinical-stage biotechnology company focused on the discovery and development of novel, small molecule, highly targeted therapeutics for the treatment of cancer and fibrotic diseases Our team of scientists are based at our labs at Alderley Park, Cheshire, the UK’s largest single site life science campus. The team is made up of world class medicinal chemistry, biology and clinical capability with deep-rooted biotech and large pharma experience. Redx's lead asset, the selective ROCK2 inhibitor, zelasudil (RXC007), is in development for idiopathic pulmonary fibrosis and commenced a Phase 2 clinical trial in Q4 2022. Redx’s second ROCK inhibitor candidate, RXC008, a GI-targeted pan-ROCK inhibitor for the treatment of fibrostenotic Crohn’s disease, commenced a Phase 1 clinical trial in Q1 2024. The Company's lead oncology product candidate, the Porcupine inhibitor, zamaporvint (RXC004), commenced a Phase 2 programme in November 2021. The Company has a strong track record of discovering new drug candidates through its core strengths in medicinal chemistry and translational science, enabling the Company to discover and develop differentiated therapeutics against biologically or clinically validated targets. Read more about our company at https://www.redxpharma.com/about-us/ If you're interested in joining us, please visit https://www.redxpharma.com to see what job vacancies we currently have.

Company Details

Employees
52
Founded
-
Address
Block 33, Mereside,united Kingdom
Phone
441625469900
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Alderley Park, Macclesfield
Looking for a particular Redx Pharma employee's phone or email?

Redx Pharma Questions

News

RCS - Redx Pharma Limited - Redx new data show zelasudil well-tolerated in IPF - TradingView

RCS - Redx Pharma Limited - Redx new data show zelasudil well-tolerated in IPF TradingView

Biotech Companies Redx Pharma, Jounce Therapeutics To Merge In USD 425 Mn Deal - BW Healthcare World

Biotech Companies Redx Pharma, Jounce Therapeutics To Merge In USD 425 Mn Deal BW Healthcare World

Redx and Jounce Announce Recommended Business Combination - GlobeNewswire

Redx and Jounce Announce Recommended Business Combination GlobeNewswire

Jazz Pharmaceuticals Enters Definitive Agreement with Redx Pharma to Acquire Global Rights to KRAS Inhibitor Program - PR Newswire

Jazz Pharmaceuticals Enters Definitive Agreement with Redx Pharma to Acquire Global Rights to KRAS Inhibitor Program PR Newswire

FDA grants orphan drug designation to zelasudil for IPF - Healio

FDA grants orphan drug designation to zelasudil for IPF Healio

Redx Pharma to open research centre at AstraZeneca’s Alderley Park site - PMLiVE

Redx Pharma to open research centre at AstraZeneca’s Alderley Park site PMLiVE

Redx Pharma plans to exit AIM and re-register as a private company - Proactive Investors

Redx Pharma plans to exit AIM and re-register as a private company Proactive Investors

Top Redx Pharma Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant